News

October 7, 2020October 7, 2020

Kynmobi Sublingual Film for ‘Off’ Episodes Now Available in US

News

Kynmobi (apomorphine hydrochloride), a sublingual film to treat “off” episodes in people with Parkinson’s disease, is now available in the United States by prescription, its developer Sunovion announced. “People ... Read more

October 7, 2020October 7, 2020

Caffeine May Also Protect Against Parkinson’s Due to LRRK2 Mutations

News

Caffeinated drinks like coffee may help to protect people from Parkinson’s disease caused by mutations in the LRRK2 gene, much as research suggests it does in preventing sporadic, or non-familial, forms of this ... Read more

October 6, 2020October 6, 2020

New Data Support Effectiveness of Ongentys for Parkinson’s ‘Off’ Periods

News

Ongentys (opicapone) can reduce the extent of “off” periods in people with Parkinson’s disease being treated with levodopa, new clinical trial data show. The data were presented at the American ... Read more

October 6, 2020October 6, 2020

BIAL Acquires Parkinson’s Treatment LTI-291, Opens US Research Center

News

Portuguese pharmaceutical company BIAL has announced the opening of a Parkinson’s disease research facility in Cambridge, Mass., as part of its expansion to the United States under the name ... Read more

October 5, 2020October 5, 2020

FDA Accepts New Drug Application for IRLAB’s Mesdopetam for Dyskinesia

News

The U.S. Food and Drug Administration (FDA) has accepted an investigational new drug application for mesdopetam (IRL790), an experimental therapy for reducing levodopa-induced dyskinesia, or involuntary movements, in people ... Read more

October 2, 2020October 2, 2020

Parkinson’s May Have 2 Distinct Subtypes, Researchers Suggest

News

Parkinson’s disease can be characterized as two different subtypes: one that starts in the brain and one that starts in the gut, a recent study suggests. This knowledge may ... Read more

October 2, 2020October 2, 2020

Spinal Cord Stimulation Alleviates Parkinson’s Pain in Small Study

News

Spinal cord stimulation can effectively decrease pain, and also may help alleviate motor symptoms, in people with Parkinson’s disease (PD), regardless of whether patients have previously undergone deep brain stimulation, ... Read more

October 1, 2020October 1, 2020

PD GENEration Study Now Includes At-home Genetic Testing and Multilingual Counseling

News

The Parkinson’s Foundation has expanded its PD GENEration national study to include at-home genetic testing and virtual counseling in Spanish as well as English. Opened in 2019 through the organization and ... Read more

October 1, 2020October 1, 2020

FDA Opposes Use of ‘Silver’ Dental Filings for Parkinson’s Patients, Others

News

New guidance from the U.S. Food and Drug Administration (FDA) recommends that dental amalgams — a silver-colored tooth filling that contains mercury — no longer be used with select groups ... Read more

September 30, 2020October 2, 2020

Stem Cell Therapy Repairs Parkinson’s Degeneration in Mice, Study Shows

News

Human stem cells can repair Parkinson’s disease-damaged neural circuits and restore motor function in mice, a recent study found. The study, “Human Stem Cell-Derived Neurons Repair Circuits and Restore ... Read more

Pin It on Pinterest